Skip to main content

Table 4 Correlation between QLQ-BN20 with resilience, depression and anxiety (construct validity)

From: Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients

QLQ-BN20 Resilience score Depression score Anxiety score
Future uncertainty  − 0.473 (< 0.001)* 0.614 (< 0.001)* 0.514 (< 0.001)*
Symptoms    
Visual disorder  − 0.347 (< 0.001)* 0.277 (< 0.001)* 0.139 (0.029)*
Motor dysfunction  − 0.571 (< 0.001)* 0.458 (< 0.001)* 0.209 (0.001)*
Communication deficit  − 0.514 (< 0.001)* 0.425 (< 0.001)* 0.211 (0.001)*
Headache  − 0.121 (0.054) 0.236 (< 0.001)* 0.246 (< 0.001)*
Seizures  − 0.168 (0.008)* 0.149 (0.018)* 0.014 (0.822)
Drowsiness  − 0.408 (< 0.001)* 0.442 (< 0.001)* 0.262 (< 0.001)*
Hair loss  − 0.196 (0.002)* 0.144 (0.022)* 0.138 (0.029)*
Itchy skin  − 0.166 (0.008) * 0.185 (0.003)* 0.145 (0.022)*
Weakness in leg  − 0.478 (< 0.001)* 0.437 (< 0.001)* 0.284 (< 0.001)*
Bladder control  − 0.218 (0.001)* 0.277 (< 0.001)* 0.220 (< 0.001)*
  1. r = Pearson correlation coefficient
  2. *Significant at p value < 0.05